F
Francesco Pantano
Researcher at Università Campus Bio-Medico
Publications - 125
Citations - 3542
Francesco Pantano is an academic researcher from Università Campus Bio-Medico. The author has contributed to research in topics: Cancer & Bone metastasis. The author has an hindex of 27, co-authored 110 publications receiving 2569 citations. Previous affiliations of Francesco Pantano include University of Lyon & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Tissue invasion and metastasis: Molecular, biological and clinical perspectives.
Wen Guo Jiang,Andrew James Sanders,Masaru Katoh,H. Ungefroren,Frank Gieseler,Mark E. Prince,Sarah K. Thompson,Massimo Zollo,Daniela Spano,P. Dhawan,Daniel Sliva,Pochi R. Subbarayan,Malancha Sarkar,Kanya Honoki,Hiromasa Fujii,Alexandros G. Georgakilas,Amedeo Amedei,Elena Niccolai,Amr Amin,S. Salman Ashraf,Lin Ye,William G. Helferich,Xujuan Yang,Chandra S. Boosani,Gunjan Guha,Maria Rosa Ciriolo,Katia Aquilano,Sophie Chen,Asfar S. Azmi,W N Keith,Alan Bilsland,Dipita Bhakta,Dorota Halicka,Somaira Nowsheen,Francesco Pantano,Daniele Santini +35 more
TL;DR: This review lists the disruption of E-cadherin and tight junctions, key signaling pathways, including urokinase type plasminogen activator (uPA), phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene (PI3K/AKT), focal adhesion kinase (FAK), β-catenin/zinc finger E-box binding homeobox 1 (ZEB
Journal ArticleDOI
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial.
Chiara Cremolini,Daniele Rossini,Emanuela Dell'Aquila,Sara Lonardi,Elena Conca,Marzia Del Re,Adele Busico,Filippo Pietrantonio,Romano Danesi,Giuseppe Aprile,Emiliano Tamburini,Carlo Barone,Gianluca Masi,Francesco Pantano,Francesca Pucci,Domenico Corsi,Nicoletta Pella,Francesca Bergamo,Eleonora Rofi,C. Barbara,Alfredo Falcone,Daniele Santini +21 more
TL;DR: This is the first prospective demonstration that a rechallenge strategy with cetuximab and irinotecan may be active in patients with RAS and BRAF wild-type mCRC with acquired resistance to first-line irinOTecan- and cetUXimab-based therapy.
Journal ArticleDOI
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Keith I. Block,Charlotte Gyllenhaal,Leroy Lowe,Amedeo Amedei,A.R.M. Ruhul Amin,Amr Amin,Katia Aquilano,Jack L. Arbiser,Jack L. Arbiser,Alexandra Arreola,Alla Arzumanyan,S. Salman Ashraf,Asfar S. Azmi,Fabian Benencia,Dipita Bhakta,Alan Bilsland,Anupam Bishayee,Stacy W. Blain,Penny B. Block,Chandra S. Boosani,Thomas E. Carey,Amancio Carnero,Marianeve Carotenuto,Stephanie C. Casey,Mrinmay Chakrabarti,Rupesh Chaturvedi,Georgia Zhuo Chen,Helen Chen,Sophie Chen,Yi Charlie Chen,Beom K. Choi,Maria Rosa Ciriolo,Helen M. Coley,Andrew Collins,Marisa Connell,Sarah Crawford,Colleen S. Curran,Charlotta Dabrosin,Giovanna Damia,Santanu Dasgupta,Ralph J. DeBerardinis,William K. Decker,Punita Dhawan,Anna Mae Diehl,Jin-Tang Dong,Q. Ping Dou,Janice E. Drewa,Eyad Elkord,Bassel F. El-Rayes,Mark A. Feitelson,Dean W. Felsheru,Lynnette R. Ferguson,Carmela Fimognari,Gary L. Firestone,Christian Frezza,Hiromasa Fujii,Mark M. Fuster,Daniele Generali,Alexandros G. Georgakilas,Frank Gieseler,Michael Gilbertson,Michelle F. Green,Brendan Grue,Gunjan Guhal,Dorota Halicka,William G. Helferich,Petr Heneberg,Patricia Hentosh,Matthew D. Hirschey,Lorne J. Hofseth,Randall F. Holcombe,Kanya Honoki,Hsue-Yin Hsu,Gloria S. Huang,Lasse Jensen,Lasse Jensen,Wen Guo Jiang,Lee W. Jones,Phillip Karpowicz,W. Nicol Keith,Sid P. Kerkar,Gazala Khan,Mahin Khatami,Young Hee Ko,Omer Kucuk,Rob J. Kulathinal,Nagi B. Kumar,Byoung S. Kwon,Anne Leb,Michael A. Leab,Ho Young Lee,Terry Lichtor,Liang Tzung Lin,Jason W. Locasale,Balakrishna L. Lokeshwar,Valter D. Longo,Costas A. Lyssiotis,Karen L. MacKenzie,Meenakshi Malhotra,Maria Marino,María L. Martínez-Chantar,Ander Matheu,Christopher Maxwellx,Eoin McDonnell,Alan K. Meeker,Mahya Mehrmohamadi,Kapil Mehta,Gregory A. Michelotti,Ramzi M. Mohammad,Sulma I. Mohammed,D. James Morré,Irfana Muqbil,Vinayak Muralidharcq,Vinayak Muralidharcq,Michael P. Murphy,Ganji Purnachandra Nagaraju,Rita Nahta,Elena Niccolai,Somaira Nowsheen,Carolina Panis,Francesco Pantano,Virginia R. Parslow,Graham Pawelec,Peter L. Pedersen,Brad Poore,Deepak Poudyal,Satya Prakash,Mark E. Prince,Lizzia Raffaghello,Jeffrey C. Rathmell,W. Kimryn Rathmell,Swapan K. Ray,Jörg Reichrath,Sarallah Rezazadeh,Domenico Ribatti,Luigi Ricciardiello,R. Brooks Robeydf,R. Brooks Robeydf,Francis Rodierdh,H.P. Vasantha Rupasinghe,Gian Luigi Russo,Elizabeth P. Ryan,Abbas Samadi,Isidro Sánchez-García,Andrew James Sanders,Daniele Santini,Malancha Sarkar,Tetsuro Sasada,Neeraj K. Saxena,Rodney E. Shackelford,H. M. C. Shantha Kumara,Dipali Sharma,Dong M. Shin,David Sidransky,Markus D. Siegelin,Emanuela Signori,Neetu Singh,Sharanya Sivanand,Daniel Sliva,Carl Smythe,Carmela Spagnuolo,Diana M. Stafforini,John Stagg,Pochi R. Subbarayan,Tabetha Sundin,Wamidh H. Talib,Sarah K. Thompson,Phuoc T. Tran,Hendrik Ungefroren,Matthew G. Vander Heiden,Vasundara Venkateswaran,Dass S. Vinay,Panagiotis J. Vlachostergios,Zongwei Wang,Kathryn E. Wellen,Richard L. Whelan,Eddy S. Yang,Huanjie Yang,Xujuan Yang,Paul Yaswen,Clement G. Yedjou,Xin Yin,Jiyue Zhu,Massimo Zollo +183 more
TL;DR: An international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broad-spectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms, and results suggest that a broad-spectrums approach should be feasible from a safety standpoint.
Journal ArticleDOI
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.
Daniele Santini,Gaia Schiavon,Gaia Schiavon,Bruno Vincenzi,Laura Maria Gaeta,Francesco Pantano,Antonio Russo,Cinzia Ortega,Camillo Porta,Sara Galluzzo,Grazia Armento,Nicla La Verde,Cinzia Caroti,Isabelle Treilleux,Alessandro Ruggiero,Giuseppe Perrone,Raffaele Addeo,Philippe Clézardin,Andrea Onetti Muda,Giuseppe Tonini +19 more
TL;DR: This is the first demonstration of the role of RANK expression in primary tumors as a predictive marker of bone metastasis occurrence and SDFS in a large population of breast cancer patients.
Journal ArticleDOI
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis.
Francesca Fr Bertani,Pamela Mozetic,Marco Fioramonti,Michele Iuliani,Giulia Ribelli,Francesco Pantano,Daniele Santini,Giuseppe Tonini,Marcella Trombetta,Luca Businaro,Stefano Selci,Alberto Rainer,Alberto Rainer +12 more
TL;DR: The results confirm the possibility to perform single-cell-level in vitro classification of M1 vs. M2 macrophages in a non-invasive and label-free manner with a high accuracy, supporting the idea of applying the technique to the study of complex interacting cellular systems, such in the case of tumour-immunity in vitro models.